Today: 9 April 2026
DroneShield stock (ASX:DRO) slides as JPMorgan pops up as 5% holder — what investors watch next
12 January 2026
2 mins read

DroneShield stock (ASX:DRO) slides as JPMorgan pops up as 5% holder — what investors watch next

Sydney, Jan 12, 2026, 11:02 AEDT — Regular session

  • DroneShield slipped 3.7% to A$3.87 by late morning, while the ASX 200 gained roughly 0.7%.
  • A recent filing revealed JPMorgan Chase & Co and its affiliates have surpassed Australia’s 5% “substantial holder” threshold in DroneShield.
  • Traders are eyeing contract cash receipts for the March quarter alongside the company’s upcoming governance and earnings milestones.

Shares of DroneShield Ltd slipped on Monday after a filing revealed JPMorgan Chase & Co and its affiliates had taken a substantial stake in the counter-drone company. By 10:40 a.m. AEDT, the stock had dropped 3.7% to A$3.87, down from a prior close of A$4.02. Meanwhile, the S&P/ASX 200 index rose roughly 0.7%.

This filing matters because DroneShield has remained a high-beta stock on the Australian market, reacting sharply to contract announcements and governance updates. When a major holder appears — even through a global bank — it can shift the short-term view on positioning.

In Australia, holding 5% voting power in a listed company triggers a mandatory “substantial holder” notice. Though this 5% threshold is automatic, it can still influence prices as investors debate if a new stake represents “real money” or just stock shuffling through lending and trading desks.

On Jan. 7, JPMorgan Chase & Co and its affiliates crossed the 5% voting power threshold, holding roughly 46.5 million shares, the filing revealed. The stake largely stemmed from securities lending and prime brokerage setups—meaning many shares were “on loan”—rather than a straightforward ownership position, the notice added.

Securities lending involves temporarily loaning shares with a commitment to return them, usually to facilitate settlement or short selling. This can cause the disclosed “relevant interest” to fluctuate sharply and reverse just as fast.

DroneShield offers counter-UAS (counter-drone) systems—equipment and software designed to detect and neutralize unauthorized drones—for military, government, and critical infrastructure clients.

Traders remain focused on near-term deliveries and payment timelines from recent contracts. In a Dec. 30 ASX announcement, DroneShield revealed it secured an $8.2 million order from a western military client and reported roughly $97.7 million in “locked in” revenue heading into 2026, not counting that latest deal pending delivery timing.

DroneShield announced earlier it secured a $49.6 million contract through a European reseller. Deliveries and payments are slated to wrap up in the March quarter.

The company also secured a distinct $6.2 million contract targeting a military client in Asia Pacific, with delivery and payment slated for 2026.

Defence-related stocks showed mixed moves: Austal climbed roughly 0.7% by late morning, whereas Electro Optic Systems slipped about 0.2%.

Still, today’s jump in DroneShield seems tied to stock-specific factors. If the JPMorgan disclosure signals lending activity and hedging instead of outright buying, that “stake” might shrink as positions unwind. Plus, any hiccups in deliveries or delays in cash from recent orders could quickly sour sentiment.

Investors are keeping an eye on governance actions too. In December, DroneShield announced plans to review director and executive pay, promising an update in its February remuneration report, following the rollout of a mandatory minimum shareholding policy for directors and senior managers. According to Investing.com’s calendar, the next earnings report is due March 4.

Stock Market Today

  • Guard Therapeutics Faces Potential Delisting from Nasdaq First North Growth Market
    April 9, 2026, 12:06 PM EDT. Guard Therapeutics International AB has been notified by Nasdaq that it currently fails to meet the active operations requirement, risking delisting by June 17, 2026. The company is exploring a merger or reverse acquisition to satisfy Nasdaq's operational criteria. A transaction structure is expected to be proposed in Q2 2024, allowing Nasdaq to reassess the listing status. If no agreement is reached, the board will recommend voluntary delisting and liquidation, returning available funds to shareholders. Final decisions will be taken by shareholders at a general meeting. Guard Therapeutics focuses on developing therapies for kidney diseases based on the alpha-1-microglobulin protein and is listed under the ticker GUARD.

Latest article

Palantir Stock Drops as Michael Burry Says Anthropic Is ‘Eating Its Lunch’

Palantir Stock Drops as Michael Burry Says Anthropic Is ‘Eating Its Lunch’

9 April 2026
Palantir Technologies dropped about 7% Thursday after Michael Burry said Anthropic was overtaking it in enterprise AI, putting Palantir on track to lose $34 billion in market value. Anthropic reported its annualized revenue run rate had surged past $30 billion and launched new AI tools for businesses. Nearly one in four businesses on Ramp now pays for Anthropic, according to Ramp data. Palantir’s stock still trades at 395 times earnings.
Salesforce Stock Hits Fresh 52-Week Low Despite AI Growth and $50 Billion Buyback

Salesforce Stock Hits Fresh 52-Week Low Despite AI Growth and $50 Billion Buyback

9 April 2026
Salesforce shares hit a new 52-week low Thursday, dropping 3.7% to $169.76 despite reporting 12% revenue growth and strong demand for its AI products. The broader software sector continued to slide, with the S&P 500 software and services index down about $1 trillion since January. Salesforce raised its buyback authorization to $50 billion and increased its dividend to 44 cents a share.
ServiceNow Stock Hits Fresh 52-Week Low as Analysts Cut Targets Ahead of Earnings

ServiceNow Stock Hits Fresh 52-Week Low as Analysts Cut Targets Ahead of Earnings

9 April 2026
ServiceNow shares dropped 5.1% to $92.45 by 10:20 a.m. EDT Thursday, hitting a new 52-week low after analysts at Stifel, BTIG, and Goldman Sachs cut price targets citing weak federal spending and limited 2026 growth. The company announced it will integrate AI, data, security, and governance into all products ahead of first-quarter results due April 22.
SoFi Technologies Stock Slips as Wall Street Cuts Targets Ahead of Q1 Earnings

SoFi Technologies Stock Slips as Wall Street Cuts Targets Ahead of Q1 Earnings

9 April 2026
SoFi Technologies shares fell 1.9% to $16.18 Thursday after KBW and Wells Fargo cut price targets ahead of first-quarter results due April 29. The moves follow Muddy Waters’ short position and claims of accounting issues, which SoFi denies. Affirm and LendingClub also traded lower. Barclays and other banks have trimmed targets as concerns mount over credit quality and sector valuations.
Tesla revives cheaper EV bet with compact SUV plan in China after sales strain

Tesla revives cheaper EV bet with compact SUV plan in China after sales strain

9 April 2026
Tesla is developing a smaller, cheaper electric SUV to be built first in Shanghai, sources said. The new model would cost less than the Model 3 and be smaller than the Model Y. Tesla produced 408,386 vehicles but delivered only 358,023 in Q1, as U.S. demand weakened and competition increased. Shares fell 0.8% Thursday.
Apple stock eyes January 29 earnings after rare losing streak; Evercore lifts target, keeps “top pick”
Previous Story

Apple stock eyes January 29 earnings after rare losing streak; Evercore lifts target, keeps “top pick”

Northern Star stock rebounds as ASX traders eye Jan 22 costs update after guidance cut
Next Story

Northern Star stock rebounds as ASX traders eye Jan 22 costs update after guidance cut

Go toTop